Home › Rhabdomyosarcoma › Ohio
Pag-aaral pangklinika para sa Rhabdomyosarcoma sa Ohio
5 pag-aaral para sa Rhabdomyosarcoma ang naghahanap ng mga kalahok sa mga site sa Ohio.
Opisyal na teksto ng pag-aaral (English)
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitPhase 1
24 Months – 18 Years · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06441331A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Children's Hospital Medical Center of Akron, Akron
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
Nagre-recruitPhase 3
Hanggang edad 50 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07466316Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05210374VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- Cincinnati Children's Hospital, Cincinnati
Nagre-recruitPhase 1/2
6 Months – 30 Years · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT04796012A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 2
18 Months – 40 Years · Lahat ng kasarian · Na-update Ago 12, 2025 · NCT05135975Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.